V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330010520 | 330010766 | null | null | Palliative (P) | 2017-04-14 | 2017-04-14 | Docetaxel 75mg/m2 (21 day) | N | N | 330016976 | DOCETAXEL |
| 330010521 | 330013183 | null | 13.2 | Palliative (P) | 2016-04-22 | 2016-07-20 | VAC | N | N | 330017013 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330010522 | 330005127 | 1.7 | 54.7 | Palliative (P) | 2016-11-04 | 2016-11-05 | Etoposide oral | N | N | 330017030 | ETOPOSIDE |
| 330010523 | 330005130 | null | 85.2 | Disease modification (D) | 2014-08-14 | 2014-08-15 | DA 3 + 10 | null | N | 330017052 | CAV |
| 330010524 | 330010768 | 0 | 114 | Palliative (P) | 2016-03-27 | 2016-03-30 | Methotrexate intrathecal | N | N | 330017052 | METHOTREXATE INTRATHECAL |
| 330010525 | 330012844 | 1.55 | 63.5 | Palliative (P) | 2013-11-27 | 2013-11-27 | CNS Low Grade Glioma Vinblastine | 2 | N | 330017083 | CISPLATIN + DOXORUBICIN |
| 330010526 | 330005133 | 1.59 | 0 | Curative (C) | 2016-02-08 | 2016-02-21 | Cisplatin + Etoposide po&iv 3 day | N | N | 330017091 | VINBLASTINE |
| 330010527 | 330010769 | null | 77.1 | Palliative (P) | 2012-11-19 | 2013-10-25 | Irinotecan + Temozolomide | N | N | 330017091 | IRINOTECAN + TEMOZOLOMIDE |
| 330010528 | 330005134 | null | 15.6 | Palliative (P) | 2016-07-18 | 2017-01-23 | Liposomal Doxorubicin (Caelyx) | N | N | 330017120 | LIPOSOMAL DOXORUBICIN |
| 330010529 | 330005136 | 0 | 15.1 | Palliative (P) | 2013-07-23 | 2013-08-01 | ETOPOSIDE | N | null | 330017130 | ETOPOSIDE |
| 330010530 | 330005138 | 1.58 | 66.9 | Curative (C) | 2016-11-08 | 2016-11-08 | Cisplatin + Doxorubicin | 2 | N | 330017159 | CISPLATIN + DOXORUBICIN |
| 330010531 | 330005139 | 1.68 | 58 | Palliative (P) | null | 2015-08-09 | Etoposide oral | N | null | 330017162 | ETOPOSIDE |
| 330010532 | 330010773 | 1.53 | 81 | Neo-adjuvant (N) | 2017-05-13 | 2017-05-13 | CNS Low Grade Glioma Vinblastine | N | N | 330017192 | CISPLATIN + ETOPOSIDE |
| 330010534 | 330005144 | null | 67 | Palliative (P) | 2014-01-13 | 2014-01-14 | CNS Low Grade Glioma Vinblastine | null | N | 330017225 | CAV |
| 330010535 | 330005145 | 1.67 | 106.9 | Palliative (P) | 2016-05-02 | 2016-07-30 | Azacitidine | N | N | 330017228 | CISPLATIN + DOXORUBICIN |
| 330010536 | 330005147 | 1.85 | 72.5 | Palliative (P) | 2013-05-29 | 2013-05-29 | Trabectedin | N | N | 330017238 | TRABECTEDIN |
| 330010537 | 330008814 | 1.7 | null | Palliative (P) | null | 2016-11-06 | Liposomal Doxorubicin (Caelyx) | 2 | N | 330017243 | LIPOSOMAL DOXORUBICIN |
| 330010538 | 330008816 | 1.5 | 68.4 | Palliative (P) | 2015-08-07 | 2015-11-10 | CARBOPLATIN + GEMCITABINE | N | N | 330017305 | GEMCARBO |
| 330010539 | 330012497 | 1.75 | 74 | Palliative (P) | 2016-10-02 | 2016-10-23 | CNS Low Grade Glioma Vinblastine | N | N | 330017306 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 330010542 | 330005161 | 1.66 | null | Palliative (P) | 2014-08-03 | 2014-08-13 | EW EuroEwing 2012 Arm A VIDE | N | N | 330017399 | EURO-EWING |
| 330010543 | 330011872 | 1.58 | 67 | Palliative (P) | null | 2014-04-21 | GEMCARBO | 02 | N | 330017401 | GEMCARBO |
| 330010544 | 330005165 | 1.76 | null | Palliative (P) | 2016-12-16 | 2016-12-19 | VAC | Y | N | 330017431 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 330010545 | 330005168 | null | 77 | Palliative (P) | 2016-01-10 | 2016-01-10 | CARBOPLATIN + GEMCITABINE | 02 | N | 330017436 | GEMCARBO |
| 330010546 | 330005169 | 1.77 | 117 | Disease modification (D) | 2015-05-23 | 2015-05-26 | Cisplatin + Etoposide po&iv 3 day | 02 | N | 330017436 | NIVOLUMAB |
| 330010547 | 330005170 | 1.62 | 79.3 | Palliative (P) | 2015-10-07 | 2015-11-24 | ETOPOSIDE | 2 | N | 330017464 | ETOPOSIDE |
| 330010548 | 330008824 | 1.65 | 39 | Curative (C) | null | 2016-09-07 | Cytarabine High Dose | N | N | 330017507 | CYTARABINE HIGH DOSE |
| 330010549 | 330008825 | null | 73.4 | Palliative (P) | 2013-06-23 | 2013-06-27 | EW EuroEwing 2012 Arm A VIDE | N | N | 330017510 | EURO-EWING |
| 330010550 | 330005176 | null | 74.9 | Curative (C) | 2017-05-16 | 2017-06-18 | Methotrexate intrathecal | null | null | 330017512 | METHOTREXATE INTRATHECAL |
| 330010551 | 330005179 | 1.69 | 73.8 | Palliative (P) | 2015-02-27 | 2015-03-06 | Methotrexate intrathecal | N | N | 330017544 | METHOTREXATE INTRATHECAL |
| 330010552 | 330005182 | 1.8 | 73 | Curative (C) | 2016-05-29 | 2017-02-10 | Methotrexate intrathecal | 02 | N | 330017566 | METHOTREXATE INTRATHECAL |
| 330010553 | 330005183 | null | 80 | null | 2013-07-31 | 2013-08-17 | Cyclophosphamide + Topotecan | null | Y | 330017571 | CAV |
| 330010554 | 330005184 | 1.78 | 67 | Palliative (P) | 2018-02-16 | 2018-02-16 | Liposomal Doxorubicin (Caelyx) | N | N | 330017577 | LIPOSOMAL DOXORUBICIN |
| 330010555 | 330005186 | 1.63 | 64.75 | Disease modification (D) | 2016-01-16 | 2016-02-19 | CNS HGG Temozolomide maintenance | null | null | 330017647 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 330010559 | 330005201 | 1.63 | null | Palliative (P) | 2013-06-13 | 2013-08-20 | CNS HGG Temozolomide maintenance | null | null | 330017801 | CISPLATIN + DOXORUBICIN |
| 330010560 | 330008837 | null | 23 | Curative (C) | null | 2016-11-06 | FLAG + Idarubicin | null | N | 330017807 | FLAG + IDARUBICIN |
| 330010561 | 330008839 | 1.75 | 50.8 | Palliative (P) | 2017-09-14 | 2017-09-14 | Azacitidine | 02 | N | 330017809 | AZACITIDINE |
| 330010562 | 330005208 | 1.8 | 114 | Curative (C) | 2014-08-18 | 2014-08-29 | Liposomal Doxorubicin (Caelyx) | N | N | 330017833 | LIPOSOMAL DOXORUBICIN |
| 330010564 | 330005217 | 1.66 | null | Palliative (P) | 2015-05-07 | 2015-05-07 | FLAG + Idarubicin | N | N | 330017922 | FLAG + IDARUBICIN |
| 330010566 | 330005223 | null | 80.9 | Neo-adjuvant (N) | 2015-09-02 | 2018-02-05 | Cyclophosphamide + Topotecan | N | N | 330017957 | TEMOZOLOMIDE |
| 330010567 | 330011879 | 1.67 | 8.4 | Palliative (P) | 2016-08-18 | 2016-09-19 | Methotrexate intrathecal | 01 | null | 330018009 | METHOTREXATE INTRATHECAL |
| 330010568 | 330005225 | 1.77 | 36.6 | Palliative (P) | 2017-02-07 | 2017-04-08 | Etoposide oral | N | N | 330018021 | ETOPOSIDE |
| 330010569 | 330008849 | 1.6 | 51.45 | Curative (C) | 2014-07-14 | 2014-07-14 | EURO-EWING | N | N | 330018024 | EURO-EWING |
| 330010570 | 330010797 | 1.75 | null | Curative (C) | 2018-01-08 | 2018-01-11 | VAC | null | null | 330018044 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330010571 | 330005229 | null | 58 | Palliative (P) | null | 2014-12-16 | GEMCARBO | 2 | N | 330018058 | GEMCARBO |
| 330010572 | 330005229 | 1.66 | 76.4 | Palliative (P) | null | 2015-03-13 | Liposomal Doxorubicin (Caelyx) | 02 | N | 330018058 | LIPOSOMAL DOXORUBICIN |
| 330010573 | 330005230 | 1.8 | null | Palliative (P) | 2013-08-22 | 2013-12-14 | Irinotecan + Temozolomide | N | N | 330018074 | IRINOTECAN + TEMOZOLOMIDE |
| 330010574 | 330008853 | 0 | null | Disease modification (D) | 2015-07-26 | 2015-09-23 | Trabectedin | 02 | null | 330018108 | TRABECTEDIN |
| 330010575 | 330005233 | null | 78 | Palliative (P) | 2015-01-26 | 2015-08-03 | DA 3+8 | null | null | 330018153 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 330010576 | 330005234 | 0 | 40.9 | Palliative (P) | 2015-07-20 | 2015-07-20 | EURO-EWING | 02 | null | 330018155 | EURO-EWING |
| 330010577 | 330005236 | 0 | 69.4 | Palliative (P) | 2015-04-28 | 2015-04-29 | GemCarbo Days 1+8 | N | N | 330018158 | GEMCARBO |